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strain (GLS) and mean peak strain rate (PSR) were improved significantly in PRP-
H group (GLS= -18.4%±3.2, PSR= -1.0/s±0.12) in comparison to either saline
(GLS= -12.6%±4.4, PSR= -0.6/s±0.15) (p=0.03), and MI-only groups (GLS= -
9.7%±4.1, PSR= -0.5/s±0.23) (p<0.01). Mean global circumferential (GCS) and
radial strains (GRS) showed marginal improvement in PRP-H group (GCS= -
23.4%±3.9, GRS= 26%±5.7) when compared to sham controls (GCS= -27%±4.8,
GRS= 31%±6.2) (p=0.05), saline (GCS= -21.3%±4.7, GRS= 24%±3.9) (p=0.062,
NS), and MI-only groups (GCS= -18%±5.8, GRS= 21.4%±6.8) (p=0.05). GLS im-
provement correlated with the EF%, FAC, dP/dt-max changes (r2= 0.81, 0.67, and
0.74 respectively) within all groups, but not with the PRSW.
Conclusions: 2D STE-derived ventricular strain is a reliable method to evalu-
ate the effects of intra-myocardial injection of the PRP-enhanced hydrogel which
proved to have the potential to improve injured myocardium both structurally and
functionally. GLS and GRS can indicate and correlate with subtle changes in other
gold-standard indexes.
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Introduction: Heart involvement in systemic sclerosis (SSc) affects the progno-
sis of the disease when clinically evident. SSc may be associated with myocardial
microvascular obstruction and micronecrosis is a presumible determinant of ven-
tricular dysfunction, heart failure and sudden death. The aim of this study was
to assess whether there were early changes of left atrial (LA) deformation by
speckle tracking in patients with normal ejection fraction.
Methods: We included 63 consecutive SSc patients (52±9 year-old, 53 females)
without LV dilatation and EF>55%; a control group of 19 normal individuals was
also included (50±11 years, 15 females) All underwent echocardiography, includ-
ing 2D, conventional Doppler, tissue Doppler mitral annulus (septal and lateral e’
velocities) and 2D speckle tracking of LV (global longitudinal strain) and LA (peak
left atrial longitudinal strain) by 2D speckle-tracking software (EchoPac, GE).
Results: SSc patients had normal LV volumes, ejection fraction (58±5%), E/A
and rest pulmonary systolic pressure was also normal in all patients. LA volumes
were normal in SSc patients but significantly larger than the controls (27.1±4.2
ml/m2 vs 23.5±5.9 ml/m2, p=0.002) and, in comparison with controls, E/e’ ra-
tio showed a tendency to higher values in SSc (7.1±3.0 vs 5.9±2.1, p=0.055), 4
in the grey zone. LV global longitudinal strain was significantly lower in SSc pa-
tients in comparison with the control group (-15.5±2.3 vs -18.5±1,9, p=0.002), and
peak longitudinal atrial strain was also significantly lower in SSc patients than in
the controls (16.8±3.5 vs 11,8±3,3, p=0.002). Peak longitudinal atrial strain corre-
lated with LV global longitudinal strain (R=0.58, p=0,01) and left atrial dimension
(R=0,72, p=0.003), but not with the other variables.
Conclusion: LA deformation as assessed by 2D speckle tracking showed LA
functional abnormalities early before left ventricular ejection fraction changes,
which were correlated with abnormal LV deformation and atrial size, expressing
the presence of subclinical cardiac involvement in patients with SSc.
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Background: Longitudinal myocardial strain analysis by speckle tracking echo-
cardiography (STE) is widely used for assessment of global myocardial function
but segmental analysis has not reached wide acceptance.
Purpose: To assess the accuracy of early segmental longitudinal strain to predict
functional myocardial recovery after reperfused STEMI; specifically to distinguish
infarcted from stunned myocardial segments.
Methods: Patients were enrrolled from the ongoing HIBISCUS-STEMI prospec-
tive cohort (NCT03070496). All patients underwent reperfusion therapy at the
acute phase by primary percutaneous coronary angioplasty. We conducted an
analysis on the baseline (48 h after STEMI) and 1 month follow-up STE. Vi-
sual wall motion analysis (WMS) was assessed by recommended classification
(1=normokinetic, 2=hypokinetic, 3=akinetic, 4=dyskinetic). Segmental recovery
(SegR) was defined by a WMS ≥2 at baseline becoming WMS 1 at 1-month.
Longitudinal strain analysis was performed in GE echopac PC workstation. Seg-
mental analysis was performed within the 16 myocardial segments in order to
obtain the following segmental longitudinal strain parameters: global strain (GS),
systolic strain (SS), positive strain (PS), end systolic strain (ESS), post systolic
index (PSI), pre stretch index (PST).
Results: A total of 68 patients were included in the analysis, with pre discharge
and 1 month TTE (1088 segments).
SegR occurred in 148 of 354 segments that were altered at baseline (WMS ≥2).
Baseline segmental strain values were all significantly better in SR segments.
Mean values ±SD and AUC identifying SegR were: SS -10.69 (±4.96; AUC 0.77),
ESS -10.24 (±5.08; AUC 0.76), PSI 17.4 (±24.6; AUC 0.73), GS -11.95 (±4.11;
AUC 0.73), PS 0.47 (±0.81; AUC 0.65), PST 8.20 (±21.7. AUC 0.65); Systolic
segmental strain had the best AUC (77.6%) with a cut off value of -5.9% (Se
86.5% Sp 57.8%) for SegR prediction.
From 177 akinetic or dyskinetic segments in the baseline TTE (WMS ≥3) 92 did
not improve their WMS (i.e. did not change to WMS 1–2). PSI was not statistically
different between groups, all other pre discharge segmental strain parameters
were significantly worst in the persistant akinesia segments. Mean values (±SD;
and AUC for discriminating persistence of akinesia were): GS -7.10 (±3.53; AUC
0.68), SS -4.20 (±3.99; AUC 0.65), ESS -3.70 (±4.29; AUC 0.65), 66.5 (±56.1;
AUC 0.62), PS 1.45 (±1.40; AUC 0.60), PST 43.7 (±43.0. AUC 0.60). Segmental
global strain had the best AUC (68.3%) with a cut off value of -9.9% (Se 84.8%
Sp 47.1%) for the discrimination persistant akinesia.
Conclusion: Early after reperfused STEMI, segmental strain may help to differ-
entiate infarcted from stunned myocardial segments.
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Background: Left ventricular (LV) diastolic dysfunction is associated with the
pathophysiology of heart failure with preserved ejection fraction (HFpEF) and con-
tributes importantly to exercise intolerance in HFpEF patients. Serum aldosterone
levels are high in HFpEF patients and it promotes LV hypertrophy and fibrosis,
thereby enhancing LV diastolic dysfunction. Experimental studies have reported
that mineralocorticoid receptor antagonists (MRAs), such as spironolactone and
eplerenone, ameliorate LV hypertrophy and fibrosis. Although the effects of MRAs
on LV structure and function and exercise capacity in HFpEF patients have been
examined in multiple randomized controlled trials, results are inconsistent due
partly to limited power with small sample sizes. We aimed to conduct a meta-
analysis of randomized controlled trials on the effects of MRAs on LV structure
and function and exercise capacity in HFpEF patients.
Methods and results: The search of electronic databases identified 7 studies
including 799 patients with HFpEF (Table 1). In the pooled analysis, treatment
with MRAs increased early diastolic mitral annular velocity (e’; weighted mean
difference [WMD] 0.450, 95% confidence interval [CI] 0.228 to 0.672 cm/s) and
decreased the ratio of early diastolic mitral inflow to annular velocities (E/e’; -1.489
[-2.068 to -0.910]) compared with control (Figure 1). In contrast, treatment with
MRAs did not significantly change LVEF (WMD [95% CI], 0.791 [-1.048 to 2.630]
%), LV mass index (-0.869 [-6.288 to 4.550] g/m2), left atrial volume index (-0.959
[-2.561 to 0.643] ml/m2), peak exercise oxygen uptake (0.866 [-0.744 to 2.477]
Table 1. Study characteristics
Author, year Follow-up Intervention Control Ejection fraction Entry n,
Treatment/control
(% women)
Mottram 2004 6 months Spironolactone Placebo >50% 15/15 (63%)
Mak 2009 12 months Eplerenone Usual care >45% 24/20 (54%)
Deswal 2011 6 months Eplerenone Placebo >50% 21/23 (7%)
Edlemann 2013 12 months Spironolactone Placebo >50% 213/209 (52%)
Kurrelmeyer 2014 6 months Spironolactone Placebo >50% 24/24 (100%)
Kosmala 2016 6 months Spironolactone Placebo >50% 64/67 (84%)
Upadhya 2017 9 months Spironolactone Placebo >50% 42/38 (80%)
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